BTIG Boosts PT on bluebird bio (BLUE) to $83; Sees Favorable FDA Pathway Derisking Pivotal Study Timeline
Go back to BTIG Boosts PT on bluebird bio (BLUE) to $83; Sees Favorable FDA Pathway Derisking Pivotal Study Timeline| BLUEBIRD BIO (NASDAQ: BLUE) | Delayed: 0.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.92 | 52 Week High | $95.28 | |||
| Open | $0.92 | 52 Week Low | $35.37 | |||
| Day High | $0.92 | P/E | N/A | |||
| Day Low | $0.92 | EPS | $-1.81 | |||
| Volume | 21,446 | |||||
